These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 1982272

  • 1. Repeated stimulation of dopamine D1 receptors enhances the effects of dopamine receptor agonists.
    White FJ, Hu XT, Brooderson RJ.
    Eur J Pharmacol; 1990 Dec 04; 191(3):497-9. PubMed ID: 1982272
    [No Abstract] [Full Text] [Related]

  • 2. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S, Lucki I, McGonigle P.
    Brain Res; 1992 Feb 07; 571(2):313-22. PubMed ID: 1351781
    [Abstract] [Full Text] [Related]

  • 3. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH, Starr MS.
    Neuroscience; 1987 Dec 07; 23(3):1001-10. PubMed ID: 2963970
    [Abstract] [Full Text] [Related]

  • 4. Behavioral interactions between muscimol and compounds selective for the D1 and D2 dopamine receptor subtypes.
    Asin KE, Bednarz LM.
    Neurosci Lett; 1990 Jun 08; 113(3):286-91. PubMed ID: 2143274
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of D1 and D2 dopamine agonists on stereotyped locomotion in rats.
    Eilam D, Clements KV, Szechtman H.
    Behav Brain Res; 1991 Nov 26; 45(2):117-24. PubMed ID: 1686397
    [Abstract] [Full Text] [Related]

  • 6. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM, Kelley AE.
    Neuroscience; 1990 Nov 26; 39(1):59-67. PubMed ID: 1982467
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW, Qin ZH, Weiss B.
    Neuropsychopharmacology; 1991 Jan 26; 4(1):47-55. PubMed ID: 1672250
    [Abstract] [Full Text] [Related]

  • 8. Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors.
    Braun AR, Barone P, Chase TN.
    Adv Exp Med Biol; 1986 Jan 26; 204():151-66. PubMed ID: 2947426
    [No Abstract] [Full Text] [Related]

  • 9. One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonists.
    Jiang LH, Kasser RJ, Altar CA, Wang RY.
    J Pharmacol Exp Ther; 1990 Jun 26; 253(3):1198-205. PubMed ID: 1972751
    [Abstract] [Full Text] [Related]

  • 10. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
    Serra G, Collu M, D'Aquila PS, De Montis GM, Gessa GL.
    Brain Res; 1990 Sep 17; 527(2):234-43. PubMed ID: 1979237
    [Abstract] [Full Text] [Related]

  • 11. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 17; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 12. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 17; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 13. MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease.
    Morelli M, Di Chiara G.
    Eur J Pharmacol; 1990 Jul 17; 182(3):611-2. PubMed ID: 1977595
    [No Abstract] [Full Text] [Related]

  • 14. Rotation in response to selective dopamine receptor agonists in rats with electrolytic substantia nigra lesions.
    Asin KE, Bednarz L, Montana W.
    Life Sci; 1990 Jul 17; 46(25):1817-23. PubMed ID: 1972973
    [Abstract] [Full Text] [Related]

  • 15. Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses.
    Morelli M, Fenu S, Cozzolino A, Pinna A, Carta A, Di Chiara G.
    Neuroscience; 1993 Apr 17; 53(3):673-8. PubMed ID: 8098138
    [Abstract] [Full Text] [Related]

  • 16. Microiontophoretic studies of the effects of D-1 and D-2 receptor agonists on type I caudate nucleus neurons: lack of synergistic interaction.
    Shen RY, Asdourian D, Chiodo LA.
    Synapse; 1992 Aug 17; 11(4):319-29. PubMed ID: 1354398
    [Abstract] [Full Text] [Related]

  • 17. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA, Bush LG, Gibb JW, Hanson GR.
    Brain Res; 1992 Feb 07; 571(2):260-4. PubMed ID: 1351780
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB, Criswell HE, Jensen KF, Simson PE, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1992 Aug 07; 262(2):855-65. PubMed ID: 1354257
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
    Arnt J, Hyttel J, Perregaard J.
    Eur J Pharmacol; 1987 Jan 13; 133(2):137-45. PubMed ID: 2949991
    [Abstract] [Full Text] [Related]

  • 20. Dopamine D1 and D2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons.
    Maslowski RJ, Napier TC.
    Eur J Pharmacol; 1991 Jul 23; 200(1):103-12. PubMed ID: 1685119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.